TransMedics Group Raises FY2026 Sales Guidance from $737.000M-$757.000M to $750.000M-$760.000M vs $743.798M Est
Benzinga Newsdesk 6 hours ago
NewsGuidance
TransMedics Group (NASDAQ:TMDX) raises FY2026 sales outlook from $737.000 million-$757.000 million to $750.000 million-$760.000 million vs $743.798 million estimate.
TransMedics Group (NASDAQ:TMDX) raises FY2026 sales outlook from $737.000 million-$757.000 million to $750.000 million-$760.000 million vs $743.798 million estimate.